Advertisement
Home Tags Cancer: Breast

Tag: Cancer: Breast

The risk for bone loss rises sharply in young breast cancer patients who received standard treatment

Young Breast Cancer Patients Face Higher Risk for Osteoporosis

Women diagnosed before age 50 have twice the risk versus cancer-free peers

CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 4-8

The 41st Annual CTRC-AACR San Antonio Breast Cancer Symposium The annual San Antonio Breast Cancer Symposium was held from Dec. 4 to 8...
Free flap breast reconstruction is a viable and safe procedure in elderly patients

Free Flap Breast Reconstruction Safe in Elderly Patients

Older women want breast reconstruction at rates similar to those of nonelderly breast cancer patients
Digital mammography has increased the overall cancer detection rate by 14 percent

Breast CA Detection Rate Up With Digital Mammography in the U.K.

Rate of detection increased 14 percent; detection rates higher for grade 1, 2 invasive cancers
The increased risk for breast cancer that occurs after childbirth can last more than 20 years

Higher Risk for Breast Cancer After Childbirth May Last 20+ Years

Risk peaks five years after childbirth but continues until 24 years postbirth
Women who have participated in mammography screening have a lower risk for dying from breast cancer within 10 and 20 years after diagnosis

Breast Screening Linked to Lower Risk for Breast Cancer Death

Screening linked to 60 percent lower risk for dying from breast cancer within 10 years after diagnosis
Tamoxifen at a dose of 5 mg/day is associated with a reduced risk for recurrence for women with hormone-sensitive breast intraepithelial neoplasia

SABCS: Low-Dose Tamoxifen Cuts Risk for Breast Dz

More second primary cancers and more frequent menopausal symptoms seen in tamoxifen vs. placebo arm
Black women with breast cancer have worse clinical outcomes even when 21-gene recurrence scores are similar

SABCS: Breast Cancer Outcomes Worse for Blacks Despite Similar Gene RS

Black race was associated with worse clinical outcomes among entire population
Subsequent imaging is required for 10 to 15.5 percent of women who undergo mastectomy

Imaging, Biopsy Often Still Needed After Mastectomy

10 to 15.5 percent of women undergo subsequent imaging; 6 to 8 percent undergo biopsy
For patients with residual invasive disease after neoadjuvant chemotherapy including a taxane and trastuzumab

SABCS: T-DM1 Cuts Recurrent Invasive HER2+ Breast CA Risk

Risk reduced with trastuzumab emtansine in those with residual invasive dz at sx after neoadjuvant chemo